LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.

Slides:



Advertisements
Similar presentations
TUBERCULOSIS This is the prompt slide for the TB Therapy section.
Advertisements

ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
Your name Institution/organization Meeting Date. Introduction.
TB/HIV Research Priorities: TB Preventive Therapy.
June 2004 HITCH Training Slide Set #3 Special Considerations in Antiretroviral Therapy.
PAEDIATRIC TB Jenny Handforth June Overview Why is Paediatric TB important Epidemiology- know the patients Adult v child with TB - differences?
Case discussion Michael Gardam University Health Network.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Clinical Case Female, 27 years of age 3 rd year Internal Medicine resident at the Mexicali General Hospital Never smoked; does not ingest alcoholic beverages.
1 Identifying Cases of MDR-TB Session 3. USAID TB CARE II PROJECT Old WHO recommendations RegimenIndications 4HREZ/2HR (Category I) New cases 2SHREZ/1HREZ/5HRE.
Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.
TB. Areas of Concern TB cases continue to be reported in every state Drug-resistant cases reported in almost every state Estimated million persons.
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Diagnosis of TB.
* TB is caused by a bacterium called Mycobacterium Tuberculosis. The bacteria usually attacks the lungs, but TB bacteria can attack any part of the.
Tuberculosis Presented by Vivian Pham and Vivian Nguyen.
Unit 5: IPT Isoniazid TB Preventive Therapy
Nurses SOAR! Training Curricula Series
Mycobacterium tuberculosis Jacob Kennedy. Tuberculosis is a bacterial disease.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
 Pulmonary Tuberculosis BY: MOHAMED HUSSEIN. Cause  Caused by Mycobacterium tuberculosis (M. tuberculosis)  Gram (+) rod (bacilli). Acid-fast  Pulmonary.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
“Don’t tell me TB is under control!” Understanding TB
TUBERCULOSIS * Prevention * Treatment, and * Challenges.
THEME: PULMONARY TUBERCULOSIS ESSAY Kazakh National medical university named after S.D. Asfendiyarov Department of foreign languages Made by: Kalymzhan.
HAIVN Harvard Medical School AIDS Initiative in Vietnam
Unit 9 Diagnosis and Treatment of Paediatric TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Tuberculosis in Pregnancy Max Brinsmead MB BS PhD May 2015.
NYU Medical Grand Rounds Clinical Vignette Verity Schaye MD, PGY-2 February 3, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Unit 7 Treatment of TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Unit 6 Diagnosing TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Adult Medical-Surgical Nursing Respiratory Module: Tuberculosis.
NYU Medical Grand Rounds Clinical Vignette Lisa Cioce MD, PGY-2 March 10, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 Figure 1. Number of Tuberculosis Cases: California,
Chapter 4 Cough or difficult breathing Case III. Case study: Mary is an 8 year old girl with cough and weight loss for some weeks.
Infectious Conditions of the Lower Respiratory Tract.
By: Michelle Russell.  To become familiar with the disease process of TB Transmission symptoms Precautions  Nursing Diagnoses  Interventions.
HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.
NYU Medicine Grand Rounds Clinical Vignette James Kim, M.D., PGY-2 February 26, 2014 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Module 2 TB Disease Transmission & Prevention. Pulmonary Tuberculosis Extra -Pulmonary TB an infectious disease caused by a microorganism called Mycobacterium.
Unit 5 Isoniazid Prevention Therapy: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Clinical Case Female, 27 years of age Female, 27 years of age 3 rd year Internal Medicine resident at the Mexicali General Hospital 3 rd year Internal.
Number of Tuberculosis Cases: California, Number of Tuberculosis Cases.
Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Acquired Drug Resistance  64 year old female of Hmong ethnicity with long standing, poorly controlled diabetes. No hx TB dx/tx.  11/6/08 CXR “active.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
Tuberculosis By Fion Kung. Objective  Describe tuberculosis  Describe sigh and symptoms of tuberculosis  Describe the nursing diagnosis for tuberculosis.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Figure 1. Number of Tuberculosis Cases: California, Number of Tuberculosis Cases
The Epidemiology of Tuberculosis Lex Gibson, Director Virginia TB Program.
James R. Ginder, MS, WEMT,PI, CHES Health Education Specialist Jeremy D. Hamilton Health Education Intern Hamilton County Health Department
MULTIDRUG- RESISTANT TUBERCULOSIS (MDR-TB) by Dr Mat Zuki Mat Jaeb 1.
Tuberculosis in Children: Treatment and Monitoring Module 10B - March 2010.
Case Discussion 2 - TB IN CHILDREN by Dr. Jeyaseelan P. Nachiappan & Dr. Suryati Adnan 1 Picture of CPG Cover.
TREATMENT OF TUBERCULOSIS: Prevention: BCG vaccination: It does not prevent infection but limits multiplication and spread of following infection so prevents.
EPIDEMIOLOGY OF PULMONARY TUBERCULOSIS. LEARNIN G OBJECTIVES State the diagnostic criteria of pulmonary tuberculosis Describe trend & state reasons for.
Management of the Newborn When Maternal TB Suspected
TB Awareness Practice Nurses
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
This is an archived document.
Respiratory Disorders
William Burman Denver Public Health Tuberculosis Trials Consortium
Epidemiology of pulmonary tuberculosis
Tuberculosis.
Presented by: Dr. Letshufi DSV 04th August 2016 Pretoria
Presentation transcript:

LEARNING MODULE TITLE SUBTITLE

HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several months of cough, weight loss, and fatigue. She had no underlying medical problems No known contacts with MDR-TB patients.

INITIAL CXR

DIAGNOSIS She was determined to be at risk for TB based on her symptoms and underwent testing. Her sputum was found to be smear positive with 3+ AFB.

CLINICAL COURSE Two months after starting therapy, the patient had worsening shortness of breath and cough. – She was compliant with her TB treatment. She came to the hospital and had sputum that was smear + and an CXR that showed the following findings.

The CXR showed a collapsed left lung. The patient underwent a bronchoscopy to visualize the airway to determine the problem in the left lung. FOLLOW-UP CXR

Bronchoscopy showed tuberculosis at the end of the airway (endobronchial TB) in the left airway. The patient underwent dilation of the airway and was continued on first-line drugs. BRONCHOSCOPY

CLINICAL COURSE The patient continued her first line drug regimen with good adherence and compliance After 5 months on therapy, her sputum smear remained positive (1+/2+). Sputum culture and drug susceptibility testing showed resistance to INH and Rifampicin, meeting the diagnosis for MDR- TB.

MDR-TB DIAGNOSIS The patient was switched to second-line drugs for MDR regimen, and she has steadily improved while on treatment. Her last CXR was *** Her last sputum smear/culture was *** She has *** months left on treatment

TEACHING POINTS What are the classic risk factors for MDR-TB? In patients without these classic risk factors, when would you think of testing for MDR-TB? What are the symptoms and signs of collapsed lobes of the lung? What is the treatment and follow-up for endobronchial TB?